Evidence map›Paper›PMID 40610611›Full record

ArticleScientific reports2025

Spatial panel data analysis of antimicrobial resistance in Escherichia coli in China.

Ruxin Kou, Haixia Wang, Dongdong Zou, Jinwen Hu, Yuanyang Wu, Qianqian Xu, Xinping Zhang

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ruxin KouSchool of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Haixia WangSchool of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Dongdong ZouSchool of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Jinwen HuSchool of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Yuanyang WuSchool of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Qianqian XuSchool of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Xinping ZhangSchool of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. xpzhang602@hust.edu.cn.

Funding

National Natural Science Foundation of China 72074085
6 · The paper itself

Abstract

Antimicrobial resistance has caused tremendous loss of life, health, and economic property, and Enterobacteriaceae bacteria have been classified by the World Health Organization as one of the key pathogens for which drug development is urgently needed. There is a lack of in-depth research on spatial effect analysis of Escherichia coli (E. coli) by researchers. The study was analyzed using spatial effect analysis with data from the China Antibiotic Resistance Surveillance System covering the prevalence of third-generation cephalosporins-resistant E. coli (3GCREC), carbapenem-resistant E. coli (CREC) and quinolone-resistant E. coli (QREC) in 30 provinces during 2014-2023. Spatial Durbin model and effect decomposition were used to determine the spatial effects of E. coli and their influencing factors, including Ambient temperature, Particulate matter (PM

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialEscherichia coliEscherichia coli InfectionsChinaHumansSpatial AnalysisAnti-Bacterial AgentsAntimicrobial resistanceEscherichia coliFixed effectSpatial Durbin modelSpatial effect analysis

Identifiers

PMID40610611
PMCPMC12229312

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.